BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pavlidis ET, Pavlidis TE. Role of bevacizumab in colorectal cancer growth and its adverse effects: A review. World J Gastroenterol 2013; 19(31): 5051-5060 [PMID: 23964138 DOI: 10.3748/wjg.v19.i31.5051]
URL: https://www.wjgnet.com/1007-9327/full/v19/i31/5051.htm
Number Citing Articles
1
David W. Greening, Sze Ting Lee, Hong Ji, Richard J. Simpson, Angela Rigopoulos, Carmel Murone, Catherine Fang, Sylvia Gong, Graeme O’Keefe, Andrew M. Scott. Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathwaysOncotarget 2015; 6(35): 38166 doi: 10.18632/oncotarget.6241
2
Aubrey L. Miller, Patrick L. Garcia, Karina J. Yoon. Developing effective combination therapy for pancreatic cancer: An overviewPharmacological Research 2020; 155: 104740 doi: 10.1016/j.phrs.2020.104740
3
L.Burt Nabors, Birgit Surboeck, Wolfgang Grisold. GliomasHandbook of Clinical Neurology 2016; 134: 235 doi: 10.1016/B978-0-12-802997-8.00014-1
4
M. Tampellini, A. La Salvia, G. V. Scagliotti. Novel investigational therapies for treating biliary tract carcinomaExpert Opinion on Investigational Drugs 2016; 25(12): 1423 doi: 10.1080/13543784.2016.1252330
5
Kiminori Yanagisawa, Masamitsu Konno, Hao Liu, Shinji Irie, Tsunekazu Mizushima, Masaki Mori, Yuichiro Doki, Hidetoshi Eguchi, Michiya Matsusaki, Hideshi Ishii. A Four-Dimensional Organoid System to Visualize Cancer Cell Vascular InvasionBiology 2020; 9(11): 361 doi: 10.3390/biology9110361
6
Seyed Mohammadreza Bolandi, Zohreh Abdolmaleki, Mohammad-Ali Assarehzadegan. Bevacizumab regulates inflammatory cytokines and inhibits VEGFR2 signaling pathway in an ovalbumin-induced rat model of airway hypersensitivityInflammopharmacology 2021; 29(3): 683 doi: 10.1007/s10787-021-00798-8
7
Javier Sánchez Ramírez, Mónica Bequet-Romero, Yanelys Morera Díaz, Francisco Hernández-Bernal, Ana de la Torre Santos, Katty-Hind Selman-Housein Bernal, Yenima Martín Bauta, Cimara H. Bermúdez Badell, Miladys Limonta Fernández, Marta Ayala Avila. Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumorsHeliyon 2018; 4(11): e00906 doi: 10.1016/j.heliyon.2018.e00906
8
Keiko Akahane, Katsuyuki Shirai, Masaru Wakatsuki, Kazunari Ogawa, Kyosuke Minato, Kohei Hamamoto, Satoru Takahashi, Koichi Suzuki, Jun Takahashi, Toshiki Rikiyama, Keita Matsumoto, Hirosato Mashima. Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapyClinical Case Reports 2020; 8(5): 919 doi: 10.1002/ccr3.2751
9
Yu Zhong Peng, Li Jun Yang, Hang Hong Lo, Betty Yuen Kwan Law, Vincent Kam Wai Wong. New Nanomaterials and Techniques for Tumor-targeted Systems2020; : 135 doi: 10.1007/978-981-15-5159-8_6
10
Lydia A. Dan, Salem Werdyani, Jingxiong Xu, Konstantin Shestopaloff, Angela Hyde, Elizabeth Dicks, Ban Younghusband, Jane Green, Patrick Parfrey, Wei Xu, Sevtap Savas. No associations of a set of SNPs in the Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase (MMP) genes with survival of colorectal cancer patientsCancer Medicine 2016; 5(9): 2221 doi: 10.1002/cam4.796
11
Anupam Bishayee, Keith Block. A broad-spectrum integrative design for cancer prevention and therapy: The challenge aheadSeminars in Cancer Biology 2015; 35: S1 doi: 10.1016/j.semcancer.2015.08.002
12
Eirini Panoilia, Emilie Schindler, Epaminontas Samantas, Gerasimos Aravantinos, Haralabos P. Kalofonos, Christos Christodoulou, George P. Patrinos, Lena E. Friberg, Gregory Sivolapenko. A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patientsCancer Chemotherapy and Pharmacology 2015; 75(4): 791 doi: 10.1007/s00280-015-2701-3
13
Y. Nancy You, Karin M. Hardiman, Andrea Bafford, Vitaliy Poylin, Todd D. Francone, Kurt Davis, Ian M. Paquette, Scott R. Steele, Daniel L. Feingold. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal CancerDiseases of the Colon & Rectum 2020; 63(9): 1191 doi: 10.1097/DCR.0000000000001762
14
Daniela S. Ardelean, Michelle Letarte. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasiaFrontiers in Genetics 2015; 6 doi: 10.3389/fgene.2015.00035
15
Louise M. Harkness, Anthony W. Ashton, Janette K. Burgess. Asthma is not only an airway disease, but also a vascular diseasePharmacology & Therapeutics 2015; 148: 17 doi: 10.1016/j.pharmthera.2014.11.010
16
Alexandre Filippello, Jack Porcheron, Jean Philippe Klein, Michèle Cottier, Gabriele Barabino. Affinity of Indocyanine Green in the Detection of Colorectal Peritoneal CarcinomatosisSurgical Innovation 2017; 24(2): 103 doi: 10.1177/1553350616681897
17
Adrien Guilloteau, Michal Abrahamowicz, Olayide Boussari, Valérie Jooste, Thomas Aparicio, Catherine Quantin, Karine Le Malicot, Christine Binquet. Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancerBMC Medical Research Methodology 2021; 21(1) doi: 10.1186/s12874-020-01202-9
18
Toshiaki Yoshimoto, Kozo Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Takuya Tokunaga, Masaaki Nishi, Chie Takasu, Hideya Kashihara, Yukako Takehara, Mitsuo Shimada. Bevacizumab‐associated intestinal perforation and perioperative complications in patients receiving bevacizumabAnnals of Gastroenterological Surgery 2020; 4(2): 151 doi: 10.1002/ags3.12312
19
Aikaterini-Eftychia Micha, Kyriakos Psarras, Odysseas Ouroumidis, Evangelia Siska, Efthymia Vlachaki, Aristotelis Lymperopoulos, Nikolaos Symeonidis, Christina Nikolaidou, Ioannis Venizelos, George Koliakos, Theodoros E. Pavlidis. A Time Course of Bevacizumab (Anti-VEGF) Effect on Rat Peritoneum: Relations Between Antiadhesive Action and Fibrin Regulation EnzymesSurgical Innovation 2017; 24(6): 543 doi: 10.1177/1553350617729510
20
Cutaneous Metastases in Ovarian CancerCancers 2019; 11(9): 1292 doi: 10.3390/cancers11091292
21
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment2021; : 57 doi: 10.1007/978-3-030-68334-4_5
22
N. Giribabu, P.V. Rao, N. Salleh. Nanoarchitectonics for Smart Delivery and Drug Targeting2016; : 695 doi: 10.1016/B978-0-323-47347-7.00025-2
23
Marina Palmhof, Stephanie Lohmann, Dustin Schulte, Gesa Stute, Natalie Wagner, H. Dick, Stephanie Joachim. Fewer Functional Deficits and Reduced Cell Death after Ranibizumab Treatment in a Retinal Ischemia ModelInternational Journal of Molecular Sciences 2018; 19(6): 1636 doi: 10.3390/ijms19061636
24
Ugur Uyeturk, Adnan Gucuk, Tulin Firat, Eray Kemahli, Aysel Kukner, Mehmet Emin Ozyalvacli. Effect of Mitomycin, Bevacizumab, and 5-Fluorouracil to Inhibit Urethral Fibrosis in a Rabbit ModelJournal of Endourology 2014; 28(11): 1363 doi: 10.1089/end.2014.0420
25
Jorge Pablo Grondona. Extreme Hepatic Surgery and Other Strategies2017; : 79 doi: 10.1007/978-3-319-13896-1_6
26
Adam Barsouk, Prashanth Rawla, Andreas V. Hadjinicolaou, John Sukumar Aluru, Alexander Barsouk. Targeted Therapies and Immunotherapies in the Treatment of Esophageal CancersMedical Sciences 2019; 7(10): 100 doi: 10.3390/medsci7100100
27
Lu Qi, Ying Zhang, Wenjuan Zhang, Yiqing Wang, Yue Han, Yanqing Ding. The inhibition of colorectal cancer growth by the natural product macrocarpal IFree Radical Biology and Medicine 2021; 162: 383 doi: 10.1016/j.freeradbiomed.2020.10.317
28
Apostolos Papachristos, Eleni Karatza, Haralabos Kalofonos, Gregory Sivolapenko. Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal CancerInternational Journal of Molecular Sciences 2020; 21(11): 3753 doi: 10.3390/ijms21113753
29
Su Woong Yoo, Gyungseok Oh, Abdul Mohaimen Safi, Soonjoo Hwang, Young-Seok Seo, Kyung-Hwa Lee, Young L. Kim, Euiheon Chung. Endoscopic non-ablative fractional laser therapy in an orthotopic colon tumour modelScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-19792-2
30
Isao Otsuka. Cutaneous Metastasis after Surgery, Injury, Lymphadenopathy, and Peritonitis: Possible MechanismsInternational Journal of Molecular Sciences 2019; 20(13): 3286 doi: 10.3390/ijms20133286
31
Mohammed Abdul-Latif, Katherine Townsend, Charles Dearman, Kai-Keen Shiu, Khurum Khan. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectivesCancer Treatment Reviews 2020; 88: 102030 doi: 10.1016/j.ctrv.2020.102030
32
Chuan-Fang Pan, Xi Zhang, Jing-Wen Wang, Tao Yang, Linda L. D. Zhong, Ke-Ping Shen. Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.512598
33
Fusun Ozmen, Tevfik Tolga Şahin, M. Mahir Ozmen. Current Adjuvant Therapeutic Approaches for Pancreatic CancerAdvances in Therapy 2015; 32(1): 42 doi: 10.1007/s12325-015-0177-5
34
Jae Hyun Kim, Seun Ja Park. Target Therapy in Unresectable or Metastatic Colorectal CancerThe Korean Journal of Gastroenterology 2016; 68(6): 303 doi: 10.4166/kjg.2016.68.6.303
35
Chien-Chih Yeh, Li-Jane Shih, Junn-Liang Chang, Yi-Wei Tsuei, Chang-Chieh Wu, Cheng-Wen Hsiao, Chih-Pin Chuu, Yung-Hsi Kao. Synchronous vascular endothelial growth factor protein profiles in both tissue and serum identify metastasis and poor survival in colorectal cancerScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40862-6
36
Athanasios Patsalias, Zuzana Kozovska. Personalized medicine: Stem cells in colorectal cancer treatmentBiomedicine & Pharmacotherapy 2021; 141: 111821 doi: 10.1016/j.biopha.2021.111821
37
Cindy B. Yeoh, Kathleen J. Lee, Elizabeth F. Rieth, Renee Mapes, Anna V. Tchoudovskaia, Gregory W. Fischer, Luis E. Tollinche. COVID-19 in the Cancer PatientAnesthesia & Analgesia 2020; 131(1): 16 doi: 10.1213/ANE.0000000000004884
38
Mauo-Ying Bien, Ming-Ping Wu, Wei-Lin Chen, Chi-Li Chung. VEGF Correlates with Inflammation and Fibrosis in Tuberculous Pleural EffusionThe Scientific World Journal 2015; 2015: 1 doi: 10.1155/2015/417124
39
De-cong Sun, Yan Shi, Yan-rong Wang, Yao Lv, Huan Yan, Hui Mao, Zhi-kuan Wang, Zhi-yong Wu, Wei-wei Shi, Guang-hai Dai. KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patientsScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14669-2
40
Saúl Redondo-Blanco, Javier Fernández, Ignacio Gutiérrez-del-Río, Claudio J. Villar, Felipe Lombó. New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive CompoundsFrontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00109
41
Christopher Fowell, Robert Jones, Hiroshi Nishikawa, Andrew Monaghan. Arteriovenous malformations of the head and neck: current concepts in managementBritish Journal of Oral and Maxillofacial Surgery 2016; 54(5): 482 doi: 10.1016/j.bjoms.2016.01.034
42
Jeroen A. C. M. Goos, Erienne M. V. de Cuba, Veerle M. H. Coupé, Begoña Diosdado, Pien M. Delis-Van Diemen, Cemile Karga, Jeroen A. M. Beliën, C. Willemien Menke-Van der Houven van Oordt, Albert A. Geldof, Gerrit A. Meijer, Otto S. Hoekstra, Remond J. A. Fijneman. Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver MetastasisAnnals of Surgery 2016; 263(1): 138 doi: 10.1097/SLA.0000000000001109
43
Sara Charmsaz, Andrew M. Scott, Andrew W. Boyd. Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptorsExperimental Hematology 2017; 54: 31 doi: 10.1016/j.exphem.2017.07.003
44
Elham Rostami, Olivera Casar-Borota, Olafur Gudjonsson. Adult Craniopharyngiomas2020; : 209 doi: 10.1007/978-3-030-41176-3_12
45
Samuel Lee, Deirdre J. Cohen. Pharmacotherapy for metastatic esophageal cancer: where do we need to improve?Expert Opinion on Pharmacotherapy 2019; 20(3): 357 doi: 10.1080/14656566.2018.1551881
46
Siddharth J. Modi, Vithal M. Kulkarni. Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry PerspectiveMedicine in Drug Discovery 2019; 2: 100009 doi: 10.1016/j.medidd.2019.100009
47
William Torén, Daniel Ansari, Roland Andersson. Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysisCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0715-8
48
Liu-qing Yang, Ru-yi Li, Xi-yan Yang, Qian-fei Cui, Fei-yun Wang, Guo-qiang Lin, Jian-ge Zhang. Co-administration of Shexiang Baoxin Pill and Chemotherapy Drugs Potentiated Cancer Therapy by Vascular-Promoting StrategyFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00565
49
Seon Ae Roh, In Ja Park, Yong Sik Yoon, Yi Hong Kwon, Jin Hwa Chung, Tae Won Kim, Dong Hyung Cho, Byung Ho Lim, Seon Kyu Kim, Seon Young Kim, Yong Sung Kim, Jin Cheon Kim. Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancerJournal of Cancer Research and Clinical Oncology 2016; 142(8): 1705 doi: 10.1007/s00432-016-2177-5
50
Christoph Schulz, Volker Heinemann, Kathrin Heinrich, Michael Haas, Julian W. Holch, Alessia Fraccaroli, Swantje Held, Jobst C. von Einem, Dominik P. Modest, Ludwig Fischer von Weikersthal, Frank Kullmann, Markus Moehler, Werner Scheithauer, Andreas Jung, Sebastian Stintzing. Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) studyAnti-Cancer Drugs 2020; 31(8): 856 doi: 10.1097/CAD.0000000000000965
51
Efstathios T. Pavlidis, Theodoros E. Pavlidis. Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A ReviewJournal of Investigative Surgery 2018; 31(1): 54 doi: 10.1080/08941939.2016.1269854
52
S. Takada, Y. Hoshino, H. Ito, Y. Masugi, T. Terauchi, K. Endo, M. Kimata, J. Furukawa, H. Shinozaki, K. Kobayashi, Y. Ogata. Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literatureJapanese Journal of Clinical Oncology 2015; 45(3): 286 doi: 10.1093/jjco/hyu206
53
Furong Kou, Jifang Gong, Yan Li, Jian Li, Xiaotian Zhang, Jie Li, Lin Shen. Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascitesJournal of International Medical Research 2021; 49(2): 030006052098666 doi: 10.1177/0300060520986664
54
Alexandre Dubrac, Gael Genet, Roxana Ola, Feng Zhang, Laurence Pibouin-Fragner, Jinah Han, Jiasheng Zhang, Jean-Léon Thomas, Alain Chedotal, Martin A. Schwartz, Anne Eichmann. Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits NeovascularizationCirculation 2016; 133(4): 409 doi: 10.1161/CIRCULATIONAHA.115.017537
55
A. Roger, M.-L. Sigal, P. Bagan, C. Sin, P. Bilan, B. Dakhil, C. Fargeas, J.-C. Couffinhal, E. Mahé. Ulcères des membres inférieurs développés sous inhibiteurs de tyrosine kinase (sunitinib, nilotinib)Annales de Dermatologie et de Vénéréologie 2017; 144(1): 49 doi: 10.1016/j.annder.2016.06.009
56
Asghar Fallah, Hamid Reza Heidari, Behzad Bradaran, Mahsa Mollapour Sisakht, Sirous Zeinali, Ommoleila Molavi. A gene-based anti-angiogenesis therapy as a novel strategy for cancer treatmentLife Sciences 2019; 239: 117018 doi: 10.1016/j.lfs.2019.117018
57
Jeroen A.C.M. Goos, Veerle M.H. Coupé, Mark A. van de Wiel, Begoña Diosdado, Pien M. Delis-Van Diemen, Annemieke C. Hiemstra, Erienne M.V. de Cuba, Jeroen A.M. Beliën, C. Willemien Menke - van der Houven van Oordt, Albert A. Geldof, Gerrit A. Meijer, Otto S. Hoekstra, Remond J.A. Fijneman. A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9Oncotarget 2016; 7(2): 2123 doi: 10.18632/oncotarget.6188
58
Brian Stagg, Hironori Uehara, Nathan Lambert, Ruju Rai, Isha Gupta, Bryce Radmall, Taylor Bates, Balamurali Ambati. Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft GrowthCancers 2014; 6(4): 2330 doi: 10.3390/cancers6042330
59
Nesrin Gariballa, Bassam R. Ali. Endoplasmic Reticulum Associated Protein Degradation (ERAD) in the Pathology of Diseases Related to TGFβ Signaling Pathway: Future Therapeutic PerspectivesFrontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.575608